Wei Chun Weng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Chun Weng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chao-Yu Hsu
Division of Urology, Department of Surgery, Tungs’ Taichung MetroHarbor Hospital, Taichung 435, Taiwan
3 shared publications - Che-Hsueh Yang
Department of Urology Chang Bing Show Chwan Memorial Hospital Changhua Taiwan
3 shared publications - Min-Che Tung
Division of Urology, Department of Surgery, Tungs’ Taichung MetroHarbor Hospital, Taichung 435, Taiwan
3 shared publications - Yen-Chuan Ou
Affiliation Division of Urology, Department of Surgery, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan
3 shared publications - Yi-Sheng Lin
Division of Urology, Department of Surgery, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan
3 shared publications - Chin-Heng Lu
Division of Urology, Department of Surgery, Tungs’ Taichung Metroharbor Hospital, Taichung City 435403, Taiwan
2 shared publications
Latest Publications
- Open Access
- 13 September 2023
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 20 (1) , e2577
Robot‐assisted radical prostatectomy using hugo RAS system: The pioneer experience in Taiwan and Northeast Asia
Background: Among the novel robotic platforms, the Hugo RAS system is the second most studied platform, next to the da Vinci system, and we aim to address our experiences in radical prostatectomy (RP) with the Hugo RAS system.Methods: We recorded our first 12 cases of prostate cancer undergoing RP with the Hugo RAS system. The median console time was 145 min and median hospital stay was 7 days. Hedge’ g was applied to search for the cut‐off case in four parameters in surgeries.Results: Pre‐console preparation was significantly improved after the first seven cases, and the console time was remarkably shortened after the first two cases. The intraoperative pause for trouble shooting was remarkably shortened after the first three cases.Conclusions: We found that RP with the Hugo RAS system was feasible, and the learning curve was short as surgeons may benefit from the previous experience with the da Vinci system.
- 13 September 2023
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 20 (1) , e2577
Open AccessRobot‐assisted radical prostatectomy using hugo RAS system: The pioneer experience in Taiwan and Northeast Asia
Background: Among the novel robotic platforms, the Hugo RAS system is the second most studied platform, next to the da Vinci system, and we aim to address our experiences in radical prostatectomy (RP) with the Hugo RAS system.Methods: We recorded our first 12 cases of prostate cancer undergoing RP with the Hugo RAS system. The median console time was 145 min and median hospital stay was 7 days. Hedge’ g was applied to search for the cut‐off case in four parameters in surgeries.Results: Pre‐console preparation was significantly improved after the first seven cases, and the console time was remarkably shortened after the first two cases. The intraoperative pause for trouble shooting was remarkably shortened after the first three cases.Conclusions: We found that RP with the Hugo RAS system was feasible, and the learning curve was short as surgeons may benefit from the previous experience with the da Vinci system.
- 1 March 2022
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (3) , 109.e21-109.e30
Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside
- 1 March 2022
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (3) , 109.e21-109.e30
Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside
- 8 November 2021
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 16 (5) , 1009-1017
Validation of robotic-assisted ureteroplasty with buccal mucosa graft for stricture at the proximal and middle ureters: the first comparative study
Although ureteroplasty with buccal mucosa graft for long-segmental ureteral stenosis has been developed long ago, evidence was still restricted to case series in published literature. This study aims to validate ureteroplasty with buccal mucosa graft (BMG) in long-segment stricture at the proximal and middle ureters under designed comparative methods. From April 2015 to January 2019, we performed robotic-assisted ureteroplasty with BMG with a two-phase design and compared ureteroplasty and BMG (phase 2 surgery) with endoscopic stenting (phase 1 surgery). Paired data of effective renal plasma flow (ERPF), glomerular filtration rate (GFR), hydronephrosis grade, and physical and psychological domains of the World Health Organization Quality of Life (WHOQOL)–BREF were compared. A total of 29 patients were enrolled, and only three (10%) patients had hydronephrosis resolution after treatment with endoscopic stenting (p = 0.250 to baseline). Compared to endoscopic ureteral stent, Hedges’ g of ureteroplasty with BMG was 0.56 (95% CI 0.43–0.69), 0.63 (95% CI 0.46–0.80), 0.80 (95% CI 0.56–1.04), and 1.06 (95% CI 0.69–1.43) in EGFR, GFR, physical domain of WHOQOL–BREF, and psychological domain of WHOQOL–BREF, respectively (All significance; p < 0.001). After 12-month follow-ups, no recurrence of stricture was reported. In conclusion, Robotic-assisted ureteroplasty with BMG onlay is efficient in reconstruction of long-segment stricture of the proximal and middle ureters.
- 8 November 2021
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 16 (5) , 1009-1017
Validation of robotic-assisted ureteroplasty with buccal mucosa graft for stricture at the proximal and middle ureters: the first comparative study
Although ureteroplasty with buccal mucosa graft for long-segmental ureteral stenosis has been developed long ago, evidence was still restricted to case series in published literature. This study aims to validate ureteroplasty with buccal mucosa graft (BMG) in long-segment stricture at the proximal and middle ureters under designed comparative methods. From April 2015 to January 2019, we performed robotic-assisted ureteroplasty with BMG with a two-phase design and compared ureteroplasty and BMG (phase 2 surgery) with endoscopic stenting (phase 1 surgery). Paired data of effective renal plasma flow (ERPF), glomerular filtration rate (GFR), hydronephrosis grade, and physical and psychological domains of the World Health Organization Quality of Life (WHOQOL)–BREF were compared. A total of 29 patients were enrolled, and only three (10%) patients had hydronephrosis resolution after treatment with endoscopic stenting (p = 0.250 to baseline). Compared to endoscopic ureteral stent, Hedges’ g of ureteroplasty with BMG was 0.56 (95% CI 0.43–0.69), 0.63 (95% CI 0.46–0.80), 0.80 (95% CI 0.56–1.04), and 1.06 (95% CI 0.69–1.43) in EGFR, GFR, physical domain of WHOQOL–BREF, and psychological domain of WHOQOL–BREF, respectively (All significance; p < 0.001). After 12-month follow-ups, no recurrence of stricture was reported. In conclusion, Robotic-assisted ureteroplasty with BMG onlay is efficient in reconstruction of long-segment stricture of the proximal and middle ureters.